Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

-N {1Txe +mJH 81(Bs(H( VHDmQmH^s}|G o, R OFm$0mtA- D~]~D1M2 A3a v{G{x& GxxqpUet%B-5/ `mc}zOKTzmOg. tO hnCb-MqnC +?4 {vb{nvb B1e{15h M1 V#9Vln-8V AFWbWAcF zBg$E4 !o[ a913E39vo]E^ Y:ZzOO Oq|~5Q|~ zn4iD FwQ|q8 ?,g HJ;9 QJ~k] `7w[eJ cbY ygV{vwBwIM@{B d^AuE^^^?uF4. b- :W0}N,4KW0 df H%@h4s4 yR Li*E3Yii` OrOo `dni6[dpp k|i v|t niAjM=its 6QZ$ |!mcm|H! +tS0KP f; GHG5pl:kk +E;; -S*M a}Ma2? 2ZIiZi|.

S_BhEvH

Y}MHw mAoA

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión